Connect Biopharma(CNTB)
SAN DIEGO, CA
Pharmaceutical1 H-1B visas (FY2023)Focus: Treatments for autoimmune diseases and inflammation
Connect Biopharma is a life sciences company focused on Treatments for autoimmune diseases and inflammation.
Immunology
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Home hospitalization
PneumoniaClinical Trials (1)
NCT02864420Hospitalization at Home: The Acute Care Home Hospital Program for Adults
N/ABand Connect
Rotator Cuff TearsClinical Trials (1)
NCT06733480Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
N/ABlood/saliva samples for protein/molecular analysis
Brain Injuries, TraumaticVibrant Capsule
Neurogenic Bowel DysfunctionTherapy Assistance Online
Anxiety DisordersClinical Trials (1)
NCT03390218TAO Outpatient Trial for Anxiety and Depression
N/ARemote fitting
Hearing LossUse of VirtuaCare™ for home program
Shoulder DiseaseClinical Trials (1)
NCT06016257Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study
N/AVivally system stimulation
Neurogenic BladderKairon leadership training for the autistic adult and Kairon autism accommodation training for the learning partner
AutismClinical Trials (1)
NCT07315867Better Social, Emotional Communication, Healthy Relationship and ASD Accommodation Skills: Emotional Intelligence ("EQ") Training for Autistic People and ASD Accommodation Training for People Who Care
N/AHome hospitalization
InfectionClinical Trials (1)
NCT03203759Hospital-Level Care at Home for Acutely Ill Adults
N/AFlippin' Pain Seminar Series
Chronic PainClinical Trials (1)
NCT05724667An Evaluation of a Flippin' Pain Seminar Series
N/AMulti-level, community-digital health promotion intervention
DiabetesClinical Trials (1)
NCT06607341Community Engagement Alliance Against Disparities
N/AAnodal tsDCS
Incomplete Spinal Cord InjuryActive tDCS
Incomplete Spinal Cord InjuryThe Severe Von Willebrand Disease (sVWD) Patient Registry
VWD - Von Willebrand's DiseaseClinical Trials (1)
NCT05437536The Severe Von Willebrand Disease (sVWD) Patient Registry
N/ATranscutaneous Auricular Vagus Nerve Stimulation
Chronic Incomplete Cervical Spinal Cord Injury (SCI)Standard education/exercises for hemiplegic shoulder pain
StrokeClinical Trials (1)
NCT01232218Treatment Protocol for Hemiplegic Shoulder Pain
N/APhotobiomodulation therapy
Sports-related ConcussionCBP-307
Autoimmune DiseasesClinical Trials (1)
NCT02280434Phase 1 Study Accessing the Safety and Tolerability of CBP-307
Phase 1CBP-307
Autoimmune DiseasesClinical Trials (1)
NCT04818229A Study to Investigate the Effects of CBP-307 on the Heart Rate-corrected QT Interval (QTc) in Healthy Subjects
Phase 1CBP-307
Healthy Adult SubjectsClinical Trials (1)
NCT05040113A Study On Human Mass Balance And Biotransformation
Phase 1Test drug
Healthy Adult SubjectsClinical Trials (1)
NCT05917782A Study to Evaluate the Pharmacokinetics Similarity of CBP-201 in Healthy Adult Chinese Subjects
Phase 1vitamin D3
X-linked AdrenoleukodystrophyClinical Trials (1)
NCT02595489A Pilot Study of Vitamin D in Boys With X-linked Adrenoleukodystrophy
Phase 1Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]
STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental DisorderCBP-174
Healthy Adult SubjectsClinical Trials (1)
NCT04811469Safety, Tolerability and Pharmacokinetics of CBP-174 in Healthy Adults
Phase 1umbilical cord blood
Cerebral PalsyRademikibart in prefilled syringe
Asthma AcuteClinical Trials (1)
NCT06940141Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Phase 2Rademikibart in prefilled syringe
COPD Acute ExacerbationClinical Trials (1)
NCT06940154Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Phase 2Phase 2
Clinical Trials (1)
NCT04783389A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Phase 2Double-Blind 0.2mg CBP-307
Moderate to Severe Ulcerative ColitisClinical Trials (1)
NCT04700449A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)
Phase 2Phase 2
Clinical Trials (1)
NCT04773678Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
Phase 2Phase 2
Clinical Trials (1)
NCT04444752A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis
Phase 2CBP-201
Atopic DermatitisClinical Trials (1)
NCT05905133A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD
Phase 2Phase 2
Clinical Trials (1)
NCT05017480A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
Phase 2Acetaminophen
Patency of the Ductus ArteriosusClinical Trials (1)
NCT04459117Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen
Phase 2/3CBP-201
Atopic DermatitisClinical Trials (1)
NCT05614817CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis
Phase 3Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 26 clinical trials
H-1B (2023): 1 approval
SEC Filings: 1 available
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub